title: [5 years' experience with conscious sedation with midazolam (Dormicum Roche) in stomatology].
abstract: The authors used Midazolam in dental treatment of 225 patients of both sexes (ASA I-IV). 25 patients suffering from heart diseases (ASA III-IV) were ECG monitored during the treatment. Midazolam with the biological half-life of 0.5-1.5 hours was successfully used for premedication of dental out-patients. The used doses had no significant influence on hemodynamic and respiratory values. Specific antagonist Flumazenil reduced the period of psychological recovery of the patients and thus made it possible for the patients to be dismissed within 30 minutes after the dental treatment if accompanied.
authors.affiliation: II.stomatologická klinika 1. lékarské fakulty Univerzity Karlovy, Praha, Czech Republic.
authors.forename: V
authors.initials: V
authors.lastname: Pávek
authors.forename: P
authors.initials: P
authors.lastname: Bígl
authors.forename: L
authors.initials: L
authors.lastname: Hess
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000766:Anesthesia, Dental; D016292:Procedural Sedation; D005260:Female; D006331:Heart Diseases; D006801:Humans; D006993:Hypnotics and Sedatives; D008297:Male; D008874:Midazolam; D008875:Middle Aged
chemical_list: D006993:Hypnotics and Sedatives; D008874:Midazolam
vernacular_title: Nase pĕtileté zkusenosti se sedací pri vĕdomí midazolamem (Dormicum Roche) ve stomatologii.